US Nasdaq stock alert

USA

CLOSING UPDATE: Biogen Idec hits 52-week high eighth time in one month 17 October 2017 17:54 EDT

NEWS BITES - NORTH AMERICA

This is an end of day Alert, produced after today's NASDAQ market close. It concludes the BSS News Bites intra-day Alert series (summaries below).

Biogen Idec, NASDAQ's 4th largest medical/biomedical company by market capitalisation, hit a 52-week high of $US348.65 today for the eighth time in the past one month and last traded at $US344.47. Compared with the NASDAQ-100 Index which rose 8.1 points (or 0.1%) in the day, this represented a relative price increase of 2.5%.

Technical indicators complementing today's significant uptrend:

+ The positive 7.57 MACD (Moving Average Convergence Divergence) indicator suggests a bullish signal.

+ In the last one month the stock has hit a new 52-week high eight times and in the last three months fifteen times, pointing to a significant uptrend.

+ The price lifted 3.5% in the last week and jumped 8.3% in the last month.

Fundamental measures by comparison with the sector average [in brackets] indicate:

Undervaluation:

+ Price/Earnings of 21.3 [30.8]

+ Return on Equity 30.4% [18.9%]

+ Return on Assets 16.2% [9.1%]

+ Return on Capital Employed 25.4% [15.4%]

Other Bullish Signals include:

+ Total Liabilities/EBITDA of 2 is comfortably below the Joseph Piotroski benchmark of <5.

+ Net profit margin has averaged 32.6% in the last 3 years. This is considered superior and suggests a high margin of safety.

+ As per the Du Pont analysis, Return on Equity is high at 30.4%.

Note

The stock has outperformed 76% of the NASDAQ market over the past 6 months.

Bearish Signals:

Tobin's Q Ratio is 3.2. Compared with the rest of the market the stock is overvalued and ranks in the bottom quartile of stocks by value of Q Ratio.

Overbought/Bearish:

The 1.2% discount to 12-month high of $US348.65 against the 41.0% premium to 12-month low of $US244.28 suggests the climb might be peaking.

TODAY'S ALERTS

Afternoon Alert: Biogen Idec lifts 3.5% on robust volume

17 October 2017 13:27 EDT

Biogen Idec Inc. (NASDAQ:BIIB) traded on heavy volume of 1.6 times average so far today while the price lifted $US11.63 (or 3.5%) to trade at $US347.31.

Morning Alert: Biogen Idec lifts 2.4% on robust volume

17 October 2017 11:07 EDT

Biogen Idec Inc. (NASDAQ:BIIB) traded on heavy volume of 1.8 times average so far today while the price lifted $US8.11 (or 2.4%) to trade at $US343.79.

RECENT ALERTS

CLOSING UPDATE: Biogen Idec hits 52-week high seventh time in one month

16 October 2017 17:54 EDT

Biogen Idec, NASDAQ's 4th largest medical/biomedical company by market capitalisation, hit a 52-week high of $US344.37 today for the seventh time in the past one month and last traded at $US335.68. Trading volume was 74% of average at the end of the day. Compared with the NASDAQ-100 Index which rose 22.1 points (or 0.4%) in the day, this represented a relative price change of -0.9%.

Afternoon Alert: Biogen Idec hits 52-week high seventh time in one month

16 October 2017 13:27 EDT

Biogen Idec Inc. (NASDAQ:BIIB) hit a 52-week high of $US344.37 today for the seventh time in the past one month and last traded at $US334.30. Trading volume was 1.4 times average so far today.

Biogen Idec Inc. (O:BIIB)

ISIN: US09062X1037

PermID: 4295906748

CIK: 875045

CUSIP: 09062X103

Source: www.BuySellSignals.com